-
Something wrong with this record ?
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines
J Lukas, M Pagano, Z Staskova, G Draetta, J Bartek
Language English Country England, Great Britain
Grant support
IZ95
MZ0
CEP Register
PubMed
8108113
Knihovny.cz E-resources
- MeSH
- Cell Cycle * MeSH
- Cyclin D1 MeSH
- Cyclins antagonists & inhibitors immunology metabolism MeSH
- Immunohistochemistry MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Antibodies, Monoclonal MeSH
- Tumor Cells, Cultured MeSH
- Oncogene Proteins antagonists & inhibitors immunology metabolism MeSH
- Subcellular Fractions metabolism MeSH
- Check Tag
- Humans MeSH
Among the key cell cycle regulators, cyclin D1 has been implicated most strongly in oncogenesis. This G1 cyclin is a putative proto-oncogene whose clonal rearrangement and/or amplification and mRNA overexpression occurs in several types of human neoplasias. We have now raised a series of monoclonal antibodies to human cyclin D1 and analysed its regulation at the protein level in 40 human tumour cell lines. We found that 12 cell lines displayed low or undetectable cyclin D1 protein level, while the remaining lines accumulated the protein to a level comparable to, or moderately higher than, that of four normal diploid non-immortalized cell types. The cell cycle-dependent oscillation and subcellular localization of cyclin D1 were similar in both tumour and normal cells. The protein localized to the nucleus of G1 cells, and it was reduced to immunocytochemically undetectable level in DNA-replicating cells. At the functional level, microinjection and electroporation of anti-D1 antibodies revealed that in most tumour cell lines studied, including those with amplification at the cyclin D1 locus, this cyclin is essential for cell cycle progression in G1. Some tumours, however, seem to have evolved mechanism(s) that enable them to bypass the requirement for functional cyclin D1.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13027830
- 003
- CZ-PrNML
- 005
- 20130828135245.0
- 007
- ta
- 008
- 130827s1994 enk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)8108113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lukáš, Jiří $7 xx0094305 $u Danish Cancer Society, Division for Cancer Biology, Copenhagen.
- 245 10
- $a Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines / $c J Lukas, M Pagano, Z Staskova, G Draetta, J Bartek
- 520 9_
- $a Among the key cell cycle regulators, cyclin D1 has been implicated most strongly in oncogenesis. This G1 cyclin is a putative proto-oncogene whose clonal rearrangement and/or amplification and mRNA overexpression occurs in several types of human neoplasias. We have now raised a series of monoclonal antibodies to human cyclin D1 and analysed its regulation at the protein level in 40 human tumour cell lines. We found that 12 cell lines displayed low or undetectable cyclin D1 protein level, while the remaining lines accumulated the protein to a level comparable to, or moderately higher than, that of four normal diploid non-immortalized cell types. The cell cycle-dependent oscillation and subcellular localization of cyclin D1 were similar in both tumour and normal cells. The protein localized to the nucleus of G1 cells, and it was reduced to immunocytochemically undetectable level in DNA-replicating cells. At the functional level, microinjection and electroporation of anti-D1 antibodies revealed that in most tumour cell lines studied, including those with amplification at the cyclin D1 locus, this cyclin is essential for cell cycle progression in G1. Some tumours, however, seem to have evolved mechanism(s) that enable them to bypass the requirement for functional cyclin D1.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a monoklonální protilátky $7 D000911
- 650 12
- $a buněčný cyklus $7 D002453
- 650 02
- $a kultivované buňky $7 D002478
- 650 02
- $a cyklin D1 $7 D019938
- 650 02
- $a cykliny $x antagonisté a inhibitory $x imunologie $x metabolismus $7 D016213
- 650 02
- $a lidé $7 D006801
- 650 02
- $a imunohistochemie $7 D007150
- 650 02
- $a onkogenní proteiny $x antagonisté a inhibitory $x imunologie $x metabolismus $7 D015513
- 650 02
- $a subcelulární frakce $x metabolismus $7 D013347
- 650 02
- $a nádorové buňky kultivované $7 D014407
- 700 1_
- $a Pagano, Michele
- 700 1_
- $a Stašková, Zdenka $7 xx0094306 $u Danish Cancer Society, Division for Cancer Biology, Copenhagen.
- 700 1_
- $a Draetta, Giulio
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271 $u Danish Cancer Society, Division for Cancer Biology, Copenhagen.
- 773 0_
- $t Oncogene $x 0950-9232 $g Roč. 9, č. 3 (1994), s. 707-718 $p Oncogene $w MED00003600
- 910 __
- $a ABA008 $b B 1746 $y 3 $z 0
- 990 __
- $a 20130827154923 $b ABA008
- 991 __
- $a 20130828135726 $b ABA008
- 999 __
- $a ok $b bmc $g 991787 $s 826260
- BAS __
- $a 3
- BMC __
- $x MED00003600 $i 0950-9232 $a 1994 $b 9 $c 3 $d 707-718 $m Oncogene $n Oncogene
- GRA __
- $a IZ95 $p MZ0
- LZP __
- $a NLK 2013-08/lpbo